Table 1.
Antagonist cycle protocols during the study period
| rHCG trigger | GnRHa trigger | Both | Total | |
|---|---|---|---|---|
| Number | 1169 | 264 | 22 | 1455 |
| Age (years) | 32.72 ± 6.34 [32] | 29.64 ± 5.23 [29] | 33.77 ± 5.80 [34] | 32.18 ± 6.25 [32] |
| BMI (kg/m2) | 25.77 ± 5.42 [24.7] | 25.52 ± 5.61 [24.2] | 25.52 ± 4.69 [24.3] | 25.72 ± 5.44 [24.6] |
| Duration (years) | 2.99 ± 2.58 [2] | 3.13 ± 2.55 [2] | 3.28 ± 2.38 [2.5] | 3.02 ± 2.58 [2] |
| FSH (IU/L) | 7.31 ± 3.02 [6.7] | 6.26 ± 2.14 [6.04] | 8.06 ± 5.78 [6.25] | 7.14 ± 2.96 [6.58] |
| Oocytes aspirated | 7.58 ± 4.50 [7] | 14.48 ± 7.95 [13] | 7.45 ± 4.06 [8] | 8.82 ± 5.91 [8] |
| Embryos transferred | 1.90 ± 0.69 [2] | 1.92 ± 0.65 [2] | 2.32 ± 1.09 [2] | 1.91 ± 0.69 [2] |
| Pregnant | 367 (31 %) | 69 (26 %) | 4 (18 %) | 440 (30 %) |
| Biochemical | 47 (4.0 %) | 9 (3.4 %) | 0 (0 %) | 56 (3.8 %) |
| IUP | 310 (27 %) | 49 (19 %) | 4 (18 %) | 363 (25 %) |
| EP | 10 (0.86 %) | 11 (4.17 %) | 0 (0 %) | 21 (1.44 %) |